Return to Clinical Trials Search Results

Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker (LEADLESS II)

The primary objectives of this study are to assess the safety and effectiveness of the Nanostim device from implant through 6-months in a subject population indicated for a VVI(R) pacemaker.



Recruitment Status

Past Studies